TTrialPathMatch Me to Trials
← Back to trials
RecruitingOverweight or Obesity

Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

Eligible age

18–65 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study will test a study drug called REGN20934 to see how safe and well tolerated this drug is, as well as how the drug is processed in the body for participants with overweight or obesity. The study is looking at: * What side effects REGN20934 might cause * How much REGN20934 is in the blood at different times * If the body makes antibodies to REGN20934

Sponsor: Regeneron Pharmaceuticals

Where it's recruiting

California

Glendale

Source: ClinicalTrials.gov · NCT07594093 · last updated 2026-09-25

Safety and Drug Concentrations of REGN20934 in Adults With Overweight · TrialPath